Purpose of the development: • galactose enzyme analytical destination determining galactose and derivatives thereof in various biological materials. • GLYUKOOKSIDAZA enzyme of fungal origin (its producer - fungus Penicillium vitale Pidopl et Bilai) retards the growth of staphylococci and a number of pathogenic dermatophytes.

Recommended application field: Medicine. Food industry.

Advantages over analogues: Highly effective medicines. Glucose oxidase preparation characterized by a high antibacterial activity.

The development stage readiness: Ready for application

Description of the development:
()
The Institute highlighted Galaktooksidazy producer and technology for production of the enzyme. The main advantages of the domestic drug compared with foreign counterparts - the high specificity and the absence of impurities other enzymatic activities . Used in medical practice for the diagnosis of hereditary disease galactosemia children , as well as research work . Specifications. Instructions for using the drug. Glyukooksidaza applied in medicine as an antimicrobial agent with a broad spectrum of activity for the treatment of purulent surgical diseases in food industry and also as a reagent for the determination of glucose in biological fluids. Formulations of alpha -galactosidase and alpha - ATSETILGALAKTOZAMINIDAZA mikrotsetov that are able to transform the red blood cells of groups II and III in the universal donor blood erythrocytes .

Information about newness of the development:

ноу-хау--
1 шт.

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Licence's sale
Technological document's sale
Creation of joint enterprise
Realization of finished commodity

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua